# U87 CART in Treatment of Advanced Solid Tumor

> **NCT05605197** · PHASE1 · UNKNOWN · sponsor: **Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd** · enrollment: 12 (estimated)

## Conditions studied

- Pancreatic Cancer
- Solid Tumor, Adult

## Interventions

- **DRUG:** U87 CAR-T

## Key facts

- **NCT ID:** NCT05605197
- **Lead sponsor:** Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10-19
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-10-08
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2024-05-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05605197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05605197, "U87 CART in Treatment of Advanced Solid Tumor". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05605197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*